12-Year-Olds Could Get Mpox Vaccine in EU if Approved
Bavarian Nordic today said it plans to seek European regulatory approval for its mpox vaccine for children ages 12-17. Meanwhile, medical commentator John Campbell, Ph.D., today said he believes the probability of “ongoing sustained transmission” of mpox in the West is “remarkably low.”
Aucun commentaire:
Enregistrer un commentaire